A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.

NCT00703755 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2288

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients With Metabolic Syndrome

Interventions

DRUG: Fenofibrate /Metformin
DRUG: Fenofibrate /Metformin
DRUG: Fenofibrate /Metformin
DRUG: Fenofibrate /Metformin
DRUG: Fenofibrate /Metformin
DRUG: Fenofibrate /Metformin
DRUG: Placebo

Sponsor

Solvay Pharmaceuticals